Jonathan Rubin - 28 Jan 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: SVP, Chief Medical Officer
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol: SUPN
Transactions as of: 28 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 29 Jan 2025, 17:01:18 UTC
Previous filing: 30 Dec 2024
Next filing: 21 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						6,905	28 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Performance Share Units	Award	$0	+1,875		$0.000000	1,875	28 Jan 2025	Common Stock	1,875	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes an aggregate of 310 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2	On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.